EXHIBIT 99
3250 Mary Street
Suite 402
Miami, FL 33133
Main number: 305-448-4700
Fax: 305-448-4757
www.omnicomm.com
For Immediate Release
OmniComm Systems, Inc. expands senior management.
MIAMI, FL--June 30, 2000--OmniComm Systems, Inc. (OTC-BB: OMCM), a
developer of e-health information systems and provider of online clinical trial
solutions for the pharmaceutical and healthcare industries, announced Cornelis
Wit has been appointed interim CEO.
Mr. Wit has been a member of the Board of Directors since November
1999, and has an extensive background in the pharmaceutical industry. He also
serves as President of Corporate Finance of Noesis Capital Corp. Mr. Wit was
formerly President and CEO of DMV International, Inc.
(http://www.dmv-international.com), a subsidiary of Campina Melkunie
(http://www.campina.nl). Prior to his employment with DMV International, he
served as Vice President of International Operations for Duphar where he was
responsible for the worldwide operations of its pharmaceutical division.
Mr. Wit replaces Peter S. Knezevich as CEO. Mr. Knezevich will continue
to advise and consult with the company on a variety of corporate matters with
which he is intimately involved, and will continue to serve as a Director.
In addition, OmniComm announced today it has enhanced senior management
by hiring three key employees: John A. Miller, Technical Product Manager; Paige
A. Harper, General Counsel; and Ronald T. Linares, Controller/Vice President of
Finance.
Mr. Miller most recently was Strategic Business Unit Manager for Carl
Zeiss, Inc. In that capacity, he was responsible for crafting business, product
and marketing plans for clinical investigations. Prior to that, he was Clinical
Applications Specialist for Carl Zeiss, Inc. and Surgical Navigation
Specialists. As such, he was directly responsible for system assembly and
installation, and also for customer training. In addition to his career
experience, Mr. Miller has a Masters of Engineering in electrical engineering,
and has an extensive knowledge of essential programming languages. Mr. Miller
will interface with OmniComm's customers, utilizing his technical expertise and
product rollout experience to provide optimal customized solutions for the
clinical trial industry.
<PAGE>
Ms. Harper was formerly Senior Counsel with the Office of Enforcement
at the United States Securities and Exchange Commission. Prior to her employment
with the SEC, Ms. Harper was employed by the law firm of Greenberg Traurig as an
associate in the bankruptcy and commercial litigation departments, respectively.
Ms. Harper will manage and coordinate all legal matters relating to OmniComm and
its subsidiaries, and will represent OmniComm in all matters before the SEC.
Mr. Linares was formerly Chief Financial Officer of a $50 million
consulting firm, First Performance Corp. As such, he was responsible for
strategic financial planning and all facets of the financial management process.
Mr. Linares will be responsible for financial management and strategic financial
planning for OmniComm and its subsidiaries.
About OmniComm
OmniComm (http://www.omnicomm.com) has developed a unique business
model designed to integrate health information systems and coordinate the
processes necessary to utilize health information. The development of the
internet application, TrialMaster(TM), together with the web portal, WebIPA(TM),
enables OmniComm to straddle the divide between doctors and their patients,
possessing invaluable data for the healthcare industry; and the
pharmaceutical/medical device industries which desperately needs the doctors,
patients and data required for the clinical trial industry.
TrialMaster provides the pharmaceutical/medical device companies with
an Internet based solution which greatly increases the efficiency, security and
integrity of the clinical trial process while drastically reducing the time and
expense of conducting a trial. OmniComm, with its systems integration background
and expertise, provides not only the application, but also the physical
infrastructure and networking design capabilities so fundamentally important to
maintaining an effective Internet application. WebIPA provides the interface
between patients, doctors and the clinical trial industry. It enables patients
and physicians to interact and to investigate the various opportunities to
participate in clinical trials. WebIPA also allows the clinical research
industry the ability to interface with patients and doctors, expanding the
critical population of trial participants and providing an invaluable research
database.
In conjunction with WebIPA.com (http://www.webipa.com), OmniMed
Services, Inc., a wholly owned subsidiary of OmniComm Systems, Inc. is
assembling an extensive network of physician practice groups and related
patients. OmniMed provides the clinical trial industry a vast pool of potential
physicians and patients from an extremely diverse spectrum of medical
specialties to participate in a wide variety of clinical trials. In addition,
OmniMed provides the clinical trial industry with an extensive database of
valuable information from previous clinical trials.
Safe Harbor Statement
Statements about OmniComm's future expectations, including without limitation,
future revenues and earnings, plans and objectives for the future operations,
future agreements, future economic performance, operations and all other
statements in this press release other than
<PAGE>
historical facts are "forward-looking statements" within the meeting of Section
27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of
1934, and as that term is defined in the Private Securities Litigation Reform
Act of 1995. OmniComm intends that such forward-looking statements be subject to
the safe harbors created thereby. Since these statements involve risks and
uncertainties, including but not limited to economic, competitive, governmental,
contractual and technological factors affecting OmniComm's operations, markets
and profitability, actual results could differ materially and adversely from the
expected results.
Contacts:
Lawton Jackson
OmniComm Systems, Inc.
Phone: 305-448-9143
E-mail: [email protected]
